GlassScriptPhysician profile
Molly Ann Johnson
NPI 1750506911
$334.89
in general payments reported to CMS, 2019-2025
13 companies · $73.47 in 2025
The $73.47 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.46 · 2020: $12.72 · 2021: $28.76 · 2022: $17.92 · 2023: $110 · 2024: $20.55 · 2025: $73.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $63.67 | 2019-2023 | |
| C. R. Bard, INC. & Subsidiaries | $36.77 | 2023 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $30.42 | 2019-2025 | |
| Pfizer INC. | $29.88 | 2020-2025 | |
| Alydia Health | $28.76 | 2021 | |
| Sumitomo Pharma America, INC. | $22.42 | 2023 | Myfembree |
| Organon LLC | $21.92 | 2025 | Nexplanon |
| Hologic Sales and Service, LLC | $20.55 | 2024 | Aptima |
| Teleflex LLC | $17.96 | 2025 | Quikclot |
| Myovant Sciences INC. | $17.92 | 2022 | |
| Astellas Pharma US INC | $16.37 | 2023 | Myrbetriq |
| Dexcom, INC. | $14.14 | 2023 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.